Use of Eylea for the Treatment of an Optic Nerve Hemangioma
Condition(s):Retinal HemangiomaLast Updated:August 8, 2017No longer available
Hide Studies Not Open or Pending
Condition(s):Retinal HemangiomaLast Updated:August 8, 2017No longer available
Condition(s):Optic Nerve DiseasesLast Updated:March 10, 2020Unknown status
Condition(s):Primary Open Angle Glaucoma; Normal Tension GlaucomaLast Updated:February 20, 2013Unknown status
Condition(s):GlaucomaLast Updated:April 26, 2016Completed
Condition(s):Optic Nerve DiseasesLast Updated:June 26, 2015Terminated
Condition(s):GlaucomaLast Updated:August 25, 2017Completed
Condition(s):Retinal VascularLast Updated:March 14, 2023Completed
Condition(s):BlindnessLast Updated:October 14, 2016Completed
Condition(s):Surgery; Optic Nerve and Pathway InjuryLast Updated:March 5, 2015Completed
Condition(s):Multiple Sclerosis; Neuromyelitis Optica Spectrum Disorder Attack; Neuromyelitis Optica Spectrum Disorder Relapse; Neuromyelitis Optica Spectrum Disorder Progression; Optic NeuritisLast Updated:November 14, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.